🇺🇸 FDA
Pipeline program

BIIB059, Biib059 placebo is a sterile liquid for injection. the formulation composition of the placebo is identical to that of biib059 drug product minus the active ingredient.

230LE306

Phase 3 small_molecule active

Quick answer

BIIB059, Biib059 placebo is a sterile liquid for injection. the formulation composition of the placebo is identical to that of biib059 drug product minus the active ingredient. for Systemic lupus erythematosus is a Phase 3 program (small_molecule) at Biogen Idec Ltd with 1 ClinicalTrials.gov record(s).

Program details

Company
Biogen Idec Ltd
Indication
Systemic lupus erythematosus
Phase
Phase 3
Modality
small_molecule
Status
active

Clinical trials